Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin unveils Glucagon for Injection for severe hypoglycemia in patients with diabetes mellitus in US

USFDA issues EIR for Lupin Somerset facility

Ruchika Sharma24 Jun 2024 11:18 AM IST

Mumbai: Global pharma major Lupin Limited today announced that it has received the Establishment Inspection Report (EIR) from the United States...

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Roche gets USFDA nod for chronic blood disorder treatment Crovalimab

Ruchika Sharma23 Jun 2024 4:30 PM IST

Roche has received approval from the U.S. Food and Drug Administration (USFDA) for Crovalimab for the treatment of chronic blood...

Novartis to buy Tourmaline Bio for USD 1.4 billion

JnJ completes acquisition of Proteologix

Ruchika Sharma23 Jun 2024 1:30 PM IST

New Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held...

USFDA approves expanded indication for Takeda Vonvendi for adults, children with Von Willebrand Disease

Takeda gets European Commission approval for Fruzaqla for previously treated metastatic Colorectal cancer

Ruchika Sharma23 Jun 2024 12:00 PM IST

FRUZAQLA is a selective oral inhibitor of all three VEGF receptors (-1, -2 and -3). VEGFR inhibitors play a pivotal role in blocking tumor...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

Bristol Myers Squibb application for subcutaneous Nivolumab validated by EMA

Ruchika Sharma23 Jun 2024 10:00 AM IST

Princeton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated the extension application to introduce...

USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz

WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs

Ruchika Sharma22 Jun 2024 4:46 PM IST

Geneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...

USFDA issues 4 observations for Zydus Jarod injectable manufacturing plant

Cipla Goa facility gets 6 USFDA observations

Ruchika Sharma22 Jun 2024 3:31 PM IST

Mumbai: Pharma major, Cipla, has received six inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) after...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease

Ruchika Sharma22 Jun 2024 2:21 PM IST

Spring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...

Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Sanofi names Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs

Ruchika Sharma22 Jun 2024 12:47 PM IST

Paris: Sanofi has announced the appointment of Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France's President as...

Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancer

Ruchika Sharma22 Jun 2024 11:11 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...

Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in Expansion

Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic

Ruchika Sharma21 Jun 2024 3:56 PM IST

Shanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...

Roche unveils new highly-sensitive B-cell lymphoma test

Ruchika Sharma21 Jun 2024 1:45 PM IST

Basel: Roche has announced the launch of the clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok